EIKN 8-K: SEC filing
Eikon Therapeutics
Filed with the SEC on · accession 0001193125-26-456794
EIKN filed a 8-K (current report) with the SEC on Nov 12, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Summary of the filing
Eikon Therapeutics issued a press release announcing clinical and corporate updates along with its financial results for the quarter ended September 30, 2026.
Key details
✦ Ask GOAX AI about this filing — what it means for EIKN, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for EIKN?
Click hereFrequently asked questions
What did EIKN file with the SEC on Nov 12, 2026?
EIKN filed a 8-K (SEC filing). Eikon Therapeutics issued a press release announcing clinical and corporate updates along with its financial results for the quarter ended September 30, 2026.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Other EIKN SEC filings
Get alerts when EIKN files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days